Having both DLBCL stage 2 and Waldenstrom's macroglobulinemia (WM) means there are two sets of prognosis statistics to consider. It's worth noting that these numbers are general averages — your individual outlook depends on many personal factors.
Here's a breakdown of the survival rates:
- DLBCL Stage 2 (five-year Show Full Answer
Having both DLBCL stage 2 and Waldenstrom's macroglobulinemia (WM) means there are two sets of prognosis statistics to consider. It's worth noting that these numbers are general averages — your individual outlook depends on many personal factors.
Here's a breakdown of the survival rates:
- DLBCL Stage 2 (five-year survival rate): approximately 75.5%
- Waldenstrom's macroglobulinemia (five-year survival rate): approximately 78%
- Overall DLBCL (all stages combined, five-year survival rate): approximately 65% It's also encouraging to know that treatments are constantly improving, which means people diagnosed today may have even better outcomes than these statistics suggest.
Because you're managing both conditions, your doctor is really the best person to give you a clearer picture of your individual prognosis. They can factor in your age, overall health, test results, and treatment history to give you a more personalized outlook. Don't hesitate to ask them directly — that conversation is so important.
June 1
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
